Improving outcomes of renal transplant recipients with behavioral adherence contracts: A randomized controlled trial

Marie Chisholm-Burns, Christina Spivey, J. Graff Zivin, J. K. Lee, E. Sredzinski, Elizabeth Tolley

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The objective of this randomized controlled trial was to assess the effects of a 1-year behavioral contract intervention on immunosuppressant therapy (IST) adherence and healthcare utilizations and costs among adult renal transplant recipients (RTRs). The sample included adult RTRs who were at least 1 year posttransplant, taking tacrolimus or cyclosporine and served by a specialty pharmacy. Pharmacy refill records were used to measure adherence and monthly questionnaires were used to measure healthcare utilizations. Direct medical costs were estimated using the 2009 Medicare Expenditure Panel Survey. Adherence was analyzed using the GLM procedure and the MIXED procedure of SAS. Rate ratios and 95% confidence intervals were estimated to quantify the rate of utilizing healthcare services relative to treatment assignment. One hundred fifty RTRs were enrolled in the study. Intervention group RTRs (n = 76) had higher adherence than control group RTRs (n = 74) over the study period (p < 0.01). And 76.1% of the intervention group compared with 42.7% of the control group was not hospitalized during the 1-year study period (RR = 1.785; 95% CI: 1.314, 2.425), resulting in cost savings. Thus, evidence supports using behavioral contracts as an effective adherence intervention that may improve healthcare outcomes and lower costs. A randomized controlled trial of a behavioral contract intervention targeting immunosuppressant therapy adherence finds that renal transplant recipients in the intervention group experienced improved adherence and outcomes compared to those in the control group.

Original languageEnglish (US)
Pages (from-to)2364-2373
Number of pages10
JournalAmerican Journal of Transplantation
Volume13
Issue number9
DOIs
StatePublished - Sep 1 2013

Fingerprint

Contracts
Randomized Controlled Trials
Kidney
Immunosuppressive Agents
Delivery of Health Care
Control Groups
Costs and Cost Analysis
Cost Savings
Tacrolimus
Health Expenditures
Medicare
Health Care Costs
Cyclosporine
Transplant Recipients
Therapeutics
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Improving outcomes of renal transplant recipients with behavioral adherence contracts : A randomized controlled trial. / Chisholm-Burns, Marie; Spivey, Christina; Graff Zivin, J.; Lee, J. K.; Sredzinski, E.; Tolley, Elizabeth.

In: American Journal of Transplantation, Vol. 13, No. 9, 01.09.2013, p. 2364-2373.

Research output: Contribution to journalArticle

@article{c9d77cb2ceb2465d92bb09da87a0b20a,
title = "Improving outcomes of renal transplant recipients with behavioral adherence contracts: A randomized controlled trial",
abstract = "The objective of this randomized controlled trial was to assess the effects of a 1-year behavioral contract intervention on immunosuppressant therapy (IST) adherence and healthcare utilizations and costs among adult renal transplant recipients (RTRs). The sample included adult RTRs who were at least 1 year posttransplant, taking tacrolimus or cyclosporine and served by a specialty pharmacy. Pharmacy refill records were used to measure adherence and monthly questionnaires were used to measure healthcare utilizations. Direct medical costs were estimated using the 2009 Medicare Expenditure Panel Survey. Adherence was analyzed using the GLM procedure and the MIXED procedure of SAS. Rate ratios and 95{\%} confidence intervals were estimated to quantify the rate of utilizing healthcare services relative to treatment assignment. One hundred fifty RTRs were enrolled in the study. Intervention group RTRs (n = 76) had higher adherence than control group RTRs (n = 74) over the study period (p < 0.01). And 76.1{\%} of the intervention group compared with 42.7{\%} of the control group was not hospitalized during the 1-year study period (RR = 1.785; 95{\%} CI: 1.314, 2.425), resulting in cost savings. Thus, evidence supports using behavioral contracts as an effective adherence intervention that may improve healthcare outcomes and lower costs. A randomized controlled trial of a behavioral contract intervention targeting immunosuppressant therapy adherence finds that renal transplant recipients in the intervention group experienced improved adherence and outcomes compared to those in the control group.",
author = "Marie Chisholm-Burns and Christina Spivey and {Graff Zivin}, J. and Lee, {J. K.} and E. Sredzinski and Elizabeth Tolley",
year = "2013",
month = "9",
day = "1",
doi = "10.1111/ajt.12341",
language = "English (US)",
volume = "13",
pages = "2364--2373",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Improving outcomes of renal transplant recipients with behavioral adherence contracts

T2 - A randomized controlled trial

AU - Chisholm-Burns, Marie

AU - Spivey, Christina

AU - Graff Zivin, J.

AU - Lee, J. K.

AU - Sredzinski, E.

AU - Tolley, Elizabeth

PY - 2013/9/1

Y1 - 2013/9/1

N2 - The objective of this randomized controlled trial was to assess the effects of a 1-year behavioral contract intervention on immunosuppressant therapy (IST) adherence and healthcare utilizations and costs among adult renal transplant recipients (RTRs). The sample included adult RTRs who were at least 1 year posttransplant, taking tacrolimus or cyclosporine and served by a specialty pharmacy. Pharmacy refill records were used to measure adherence and monthly questionnaires were used to measure healthcare utilizations. Direct medical costs were estimated using the 2009 Medicare Expenditure Panel Survey. Adherence was analyzed using the GLM procedure and the MIXED procedure of SAS. Rate ratios and 95% confidence intervals were estimated to quantify the rate of utilizing healthcare services relative to treatment assignment. One hundred fifty RTRs were enrolled in the study. Intervention group RTRs (n = 76) had higher adherence than control group RTRs (n = 74) over the study period (p < 0.01). And 76.1% of the intervention group compared with 42.7% of the control group was not hospitalized during the 1-year study period (RR = 1.785; 95% CI: 1.314, 2.425), resulting in cost savings. Thus, evidence supports using behavioral contracts as an effective adherence intervention that may improve healthcare outcomes and lower costs. A randomized controlled trial of a behavioral contract intervention targeting immunosuppressant therapy adherence finds that renal transplant recipients in the intervention group experienced improved adherence and outcomes compared to those in the control group.

AB - The objective of this randomized controlled trial was to assess the effects of a 1-year behavioral contract intervention on immunosuppressant therapy (IST) adherence and healthcare utilizations and costs among adult renal transplant recipients (RTRs). The sample included adult RTRs who were at least 1 year posttransplant, taking tacrolimus or cyclosporine and served by a specialty pharmacy. Pharmacy refill records were used to measure adherence and monthly questionnaires were used to measure healthcare utilizations. Direct medical costs were estimated using the 2009 Medicare Expenditure Panel Survey. Adherence was analyzed using the GLM procedure and the MIXED procedure of SAS. Rate ratios and 95% confidence intervals were estimated to quantify the rate of utilizing healthcare services relative to treatment assignment. One hundred fifty RTRs were enrolled in the study. Intervention group RTRs (n = 76) had higher adherence than control group RTRs (n = 74) over the study period (p < 0.01). And 76.1% of the intervention group compared with 42.7% of the control group was not hospitalized during the 1-year study period (RR = 1.785; 95% CI: 1.314, 2.425), resulting in cost savings. Thus, evidence supports using behavioral contracts as an effective adherence intervention that may improve healthcare outcomes and lower costs. A randomized controlled trial of a behavioral contract intervention targeting immunosuppressant therapy adherence finds that renal transplant recipients in the intervention group experienced improved adherence and outcomes compared to those in the control group.

UR - http://www.scopus.com/inward/record.url?scp=84883452621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883452621&partnerID=8YFLogxK

U2 - 10.1111/ajt.12341

DO - 10.1111/ajt.12341

M3 - Article

C2 - 23819827

AN - SCOPUS:84883452621

VL - 13

SP - 2364

EP - 2373

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 9

ER -